Akers Biosciences Inc (AKR)

 
This US company’s shares are traded by us as on the LSE. Income from them will not be treated as eligible for a reduced rate of tax. Learn more

AKR Share PerformanceMore

52 week high255.00 01/12/16
52 week low65.00 18/09/17
52 week change -167.50 (-69.07%)
4 week volume21,011 24/08/17

Media for (AKR)

Presenter: Ray, Akers, Co-Founder & Executive Chairman
29/07/2014
Presenter: Ray, Akers, Co-Founder & Executive Chairman
16/05/2014

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Appointment of U.S. VP of Sales & Distribution

Akers Bio revenues up 10%

Akers Biosciences' total revenues rose by 10% $1,865,112 in the six months to the end of June while overheads were reduced b...

Half-year Report

Announcement of half-year/second quarter financial results

Akers Bio in equity issue

Akers Biosciences has issued 10,000 shares of the company's restricted common stock to Michael Warhol, a medical adviser...

Issue of Equity

Notification of an issue of equity shares e.g. offer for subscription/offer for sale/rights issue

Akers Bio resolutions passed at AGM

Akers Biosciences has confirmed that all resolutions proposed at its annual general meeting in Philadelphia yesterday were...

Result of AGM

Notification of the result of any voting at an AGM

Akers Bio second quarter sales jump

Akers Biosciences said its second quarter sales were among the strongest since the company's admission to NASDAQ Capita...

Equity Research (AKR)

Akers Biosciences Inc.
18/08/2016
Physiomics* (PYC.L) 0.04p £1.22m The computational systems biology services company applying simulations of cell behaviour to drug development to reduce the high attrition rates of clinical trials...
Akers Biosciences Inc.
11/08/2016
ValiRx (Val.L) 39p £4.37m The life science company, which focuses on clinical stage cancer therapeutic development has received regulatory approval for its VAL401 Phase IIB Clinical Trial in Georgia...

Latest discussion posts More

  • Re: RNS : new PIFA agreement

    Maybe turned the corner here
    30-Mar-2017
    Silveroil
  • RNS : new PIFA agreement

    Looks like a potentially lucrative agreement with a group of up to 300 New York hospitals to introduce the PIFA ...
    19-Dec-2016
    gretel
  • Exciting RNS just out

    Worth noting in particular that First Check are a subsidiary of the mighty Alere ...
    1-Dec-2016
    gretel

Users' HoldingsMore

Users who hold Akers Biosciences Inc also hold..
LLOYDS GRP.32%
ID:ISIN:GB00B142G99419%
NATIONAL GRID16%
BP16%
TESCO12%

Codes & Symbols

ISINUS00973E1029
SymbolsAKR, LSE:AKR, AKR.L, AKR:LN, LON:AKR, XLON:AKR